Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bedrosian Camille L
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   3    
Direct Shares   207,963    

Indirect Shares

   0      
Direct Value   $2,319,613    

Indirect Value

   $0      
Total Shares   207,963      
Total Value   $2,319,613      


Ultragenyx Pharmaceutical Inc $2,066,893 Crinetics Pharmaceuticals, Inc. $252,720 Amylyx Pharmaceuticals, Inc. $0 Ultragenyx Pharmaceutical Inc $2,066,893 Crinetics Pharmaceuticals, Inc. $252,720 Amylyx Pharmaceuticals, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    8    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    8    
   
     Gain/Loss Ratio :
   0.0   
   -8.0   
     Percentage Gain/Loss :
     0.0%
 -261.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ultragenyx Pharmaceutical Inc RARE EVP and Chief Medical ... 2023-03-01 46,720 2018-01-30 0    Premium*  
            Crinetics Pharmaceuticals, Inc. CRNX Director 2023-06-16 6,000 2023-06-16 0    Premium*  
            Amylyx Pharmaceuticals, Inc. AMLX 2024-04-16 155,243 2023-11-27 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMLX Amylyx Pharmaceuticals, I... Chief Medical Officer   •       –      –    2024-04-16 4 A $0.00 $0 D/D 96,910 155,243 0 -
AMLX Amylyx Pharmaceuticals, I... Chief Medical Officer   •       –      –    2023-11-27 4 A $0.00 $0 D/D 58,333 58,333 0 -
CRNX Crinetics Pharmaceuticals... Director   –       •      –    2023-06-16 4 A $0.00 $0 D/D 6,000 6,000 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2023-03-01 4 S $45.25 $175,615 D/D (3,881) 46,720 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2023-03-01 4 A $0.00 $0 D/D 2,663 50,601 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2022-03-01 4 A $0.00 $0 D/D 14,000 47,938 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2022-03-01 4 S $66.62 $187,935 D/D (2,821) 33,938 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2022-01-30 4 S $66.30 $109,859 D/D (1,657) 36,759 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-10-14 4 S $81.14 $29,129 D/D (359) 38,416 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-09-02 4 AS $100.18 $250,450 D/D (2,500) 38,775 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-09-02 4 OE $55.00 $137,500 D/D 2,500 41,275 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-09-01 4 AS $100.03 $250,075 D/D (2,500) 38,775 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-09-01 4 OE $55.00 $137,500 D/D 2,500 41,275 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-05-06 4 S $113.67 $41,376 D/D (364) 38,775 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-04-15 4 AS $109.09 $545,450 D/D (5,000) 39,139 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-04-15 4 OE $55.00 $275,000 D/D 5,000 44,139 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-03-01 4 S $138.18 $627,752 D/D (4,543) 39,139 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-03-01 4 A $0.00 $0 D/D 10,136 43,682 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-01-30 4 S $140.36 $314,827 D/D (2,243) 33,546 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-01-15 4 AS $139.18 $3,479,500 D/D (25,000) 35,789 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2021-01-15 4 OE $55.00 $1,375,000 D/D 25,000 60,789 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2020-10-14 4 S $88.00 $23,056 D/D (262) 35,789 0 %
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2020-05-06 4 D $66.26 $16,499 D/D (249) 36,051 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2020-03-01 4 A $0.00 $0 D/D 12,934 37,549 0 -
RARE Ultragenyx Pharmaceutical... EVP and Chief Medical Officer   •       –      –    2020-03-01 4 D $56.08 $70,044 D/D (1,249) 36,300 0 -
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us